AMP Horizons Series: Myeloid Neoplasms with Germline Predisposition
Dr. Godley will describe our current understanding of the genes and types of deleterious DNA variants that confer an increased risk for the development of myeloid malignancies. She will discuss which patients are likely to harbor such DNA mutations and comprehensive approaches for making the diagnosis. She will also describe how to use molecular profiling of malignant cells to prioritize patients for appropriate germline genetic testing. Finally, she will describe the importance of identifying germline predisposition alleles to optimize the care of patients undergoing allogeneic hematopoietic stem cell transplantation.
- Discuss the number of genes in which deleterious variants confer increased risk for the development of myeloid malignancies.
- Describe how frequently germline mutations are identified in patients with myeloid malignancies.
- Identify patients with germline predisposition
Lucy A. Godley, MD, PhD
The University of Chicago Medicine
Nathan Montgomery, MD, PhD
T&E Committee Member
University of North Carolina
Chapel Hill, NC
Duration: 1 hr
Level of Instruction: Basic
Date Recorded: March 9, 2021
Planned and coordinated by the Training and Education Committee
Continuing Education Credit InformationCME credit: 1.0
CMLE credit: 1.0
Last day to purchase course and claim credit: March 20, 2022
AMA PRA Category 1 Credit(s)™
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of American Society for Clinical Pathology (ASCP) and Association for Molecular Pathology (AMP). The American Society for Clinical Pathology (ASCP) is accredited by the ACCME to provide continuing medical education for physicians.
The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Note: Members of AMP can access this webinar at no cost. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.